Pratila M G, Fischer M E, Alagesan R, Alagesan R, Reinsel R A, Pratilas D
Department of Anesthesiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
J Clin Anesth. 1993 Jul-Aug;5(4):268-74. doi: 10.1016/0952-8180(93)90117-w.
To compare intraoperative and recovery parameters in patients who received either propofol infusion (PI), propofol bolus (PB), or midazolam bolus (MZ) for sedation.
Randomized clinical study.
Medical/surgical patients in a specialized hospital.
Ninety patients, aged 18 to 85 years, scheduled for central venous access for chemotherapy and/or total parenteral nutrition.
In 30 patients, sedation was induced with MZ 0.02 mg/kg intravenously (i.v.), repeated every 2 to 3 minutes to achieve a sedation level of 3 (eyes closed, responds to verbal stimulus) (SL3). Maintenance was with MZ 0.005 mg/kg i.v. repeated as necessary to maintain SL3. In both propofol groups (30 patients each), induction of sedation was with a bolus of propofol 0.75 to 1.0 mg/kg i.v. Maintenance in the PB group was with propofol 0.25 mg/kg IV, repeated as necessary to maintain SL3. Maintenance in the PI group was with propofol 2 to 4 mg/kg/hr or 33 to 66 micrograms/kg/min to maintain SL3.
Blood pressure, heart rate, respiratory rate, oxygen saturation, and sedation level were monitored each minute for 5 minutes and then at 5-minute intervals during the procedure. A right atrial blood sample was taken for pH and partial pressure of carbon dioxide at maximum sedation. Adequate sedation was achieved in all three groups. The time to reach SL3 was significantly shorter in the PB group than in the PI and MZ groups (p < 0.05 and p < 0.01, respectively). Cardiovascular and respiratory parameters were remarkably stable. Immediate recovery, as judged by spontaneous eye opening, response to commands, and ability to state date of birth, was significantly shorter in both the PB and PI groups than in the MZ group (p < 0.0001). Intermediate recovery, as measured by sedation score at recovery entry, Aldrete score, and time to standing, was slower in the MZ group (p < 0.05 for the MZ group vs. the PB and PI groups for sedation score and Aldrete score; p < 0.05 for the MZ group vs. the PI group in time to standing). Psychomotor recovery, judged by digit symbol substitution tests, was significantly faster in the PB and PI groups (p < 0.05 vs. the MZ group). Amnesia, measured by picture recall, was significantly greater in the MZ group than in the PI and PB groups (p < 0.05). Mood changes were measured on a visual analog scale. All groups showed improvement. Nausea, headache, dizziness, blurred vision, appetite, tension, pain, depression, drowsiness, and ability to concentrate were evaluated in the preoperative and postoperative periods. The frequency did not differ significantly between groups due to confounding factors such as postoperative chemotherapy and premedicant drugs.
The PI, PB, and MZ groups all gave excellent sedation for patients undergoing surgical procedures with local anesthesia. Amnesia was greatest with midazolam, and recovery was more rapid with propofol.
比较接受丙泊酚输注(PI)、丙泊酚推注(PB)或咪达唑仑推注(MZ)进行镇静的患者的术中及恢复参数。
随机临床研究。
一家专科医院的内科/外科患者。
90例年龄在18至85岁之间、计划接受中心静脉置管以进行化疗和/或全胃肠外营养的患者。
30例患者静脉注射0.02 mg/kg咪达唑仑诱导镇静,每2至3分钟重复一次,以达到3级镇静水平(闭眼,对言语刺激有反应)(SL3)。维持剂量为静脉注射0.005 mg/kg咪达唑仑,必要时重复以维持SL3。在两个丙泊酚组(每组30例患者)中,静脉注射0.75至1.0 mg/kg丙泊酚诱导镇静。PB组的维持剂量为静脉注射0.25 mg/kg丙泊酚,必要时重复以维持SL3。PI组的维持剂量为丙泊酚2至4 mg/kg/小时或33至66微克/千克/分钟以维持SL3。
在手术过程中,每分钟监测血压、心率、呼吸频率、血氧饱和度和镇静水平,持续5分钟,然后每隔5分钟监测一次。在最大镇静时采集右心房血样检测pH值和二氧化碳分压。三组均实现了充分镇静。PB组达到SL3的时间显著短于PI组和MZ组(分别为p < 0.05和p < 0.01)。心血管和呼吸参数非常稳定。以自主睁眼、对指令的反应以及说出出生日期的能力判断,PB组和PI组的即刻恢复均显著短于MZ组(p < 0.0001)。以恢复时的镇静评分、Aldrete评分和站立时间衡量,MZ组的中期恢复较慢(MZ组与PB组和PI组相比,镇静评分和Aldrete评分p < 0.05;MZ组与PI组相比,站立时间p < 0.05)。以数字符号替换试验判断,PB组和PI组的精神运动恢复明显更快(与MZ组相比p < 0.05)。以图片回忆测试,MZ组的遗忘程度显著高于PI组和PB组(p < 0.05)。采用视觉模拟量表测量情绪变化。所有组均有改善。在术前和术后评估恶心、头痛、头晕、视力模糊、食欲、紧张、疼痛、抑郁、嗜睡和注意力集中能力。由于术后化疗和术前用药等混杂因素,各组之间的发生率无显著差异。
PI组、PB组和MZ组对接受局部麻醉手术的患者均提供了良好的镇静效果。咪达唑仑的遗忘作用最强,丙泊酚的恢复更快。